Skip to main content
Apyx Medical Corp logo

Apyx Medical Corp — Investor Relations & Filings

Ticker · APYX ISIN · US0323472052 LEI · 5299009QZVYUYO082S45 US Manufacturing
Open in API
Filings indexed 969 across all filing types
Latest filing 2002-03-25 Annual Report
Country US United States of America
Listing US APYX

About Apyx Medical Corp

https://apyxmedical.com/

Apyx Medical Corporation is an advanced energy technology company that develops, manufactures, and markets innovative products for surgical and cosmetic markets. The company's proprietary Helium Plasma Platform, which is the foundation for its Renuvion® and J-Plasma® brands, utilizes a unique combination of helium plasma and radiofrequency (RF) energy. These systems are designed to deliver controlled energy for the cutting, coagulation, and ablation of soft tissue, with a primary focus on aesthetic procedures for skin tightening and body contouring. Apyx Medical, formerly Bovie Medical, leverages its expertise in energy-based waveforms to provide transformative solutions for surgeons and their patients.

Recent filings

Filing Released Lang Actions
10KSB 2001
Annual Report Classification · 100% confidence The document is titled 'FORM 10-KSB' and is described as an 'ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934' for the fiscal year ended December 31, 2001. It contains detailed sections typical of an annual report, including business description, properties, legal proceedings, management discussion and analysis, financial statements, directors and officers information, remuneration, and security ownership. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The presence of detailed business and financial information confirms it is the official annual report filing. Therefore, the correct classification is Annual Report (10-K).
2002-03-25 English
QUARTERLY 09/30/2001
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-QSB/A' and is a quarterly report pursuant to the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2001. It contains detailed consolidated financial statements including balance sheets, statements of operations, cash flows, and notes to the financial statements. The document includes management's discussion and analysis, legal proceedings, and other information typical of an interim quarterly report. The length of the document (15,000 characters) and the presence of substantive financial data confirm it is the actual report, not just an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2001-11-21 English
QUARTERLY 09/30/2001
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-QSB' and is a quarterly report pursuant to the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2001. It contains detailed consolidated financial statements including balance sheets, statements of operations, cash flows, and notes to the financial statements. The content includes unaudited interim financial data and management's discussion and analysis, which are typical components of an interim or quarterly report. The document length is substantial (15,000 characters) and contains actual financial data, not just an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2001-11-13 English
10QSB 06/30/01
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-QSB' and is identified as a 'QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934' for the quarterly period ended June 30, 2001. It contains detailed consolidated financial statements including balance sheets, statements of operations, cash flows, and notes to the financial statements. The length of the document is approximately 15,000 characters, indicating it is a full report rather than a brief announcement. The presence of interim financial data and management discussion confirms it is a quarterly report. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2001-08-17 English
BOVIE EXTENSION 10QSB 03/31/2001
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25 filed with the SEC, which is a Notification of Late Filing. It specifically states that the company is notifying the SEC of a delay in filing its Form 10-Q for the quarter ended June 30, 2001. The document explains the reasons for the delay and the expected filing date extension. It does not contain the actual financial report or substantive financial data but is rather a regulatory notification about the late filing of a quarterly report. According to the classification rules, such notifications are categorized under Regulatory Filings (RNS) as they are compliance documents and do not constitute the report itself.
2001-08-14 English
2001 STATUTORY AND NON-STATUTORY STOCK
Regulatory Filings Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as stock option plans. It includes detailed information about the stock option plan, indemnification provisions, and exhibits related to the plan and legal opinions. It is not a financial report, earnings release, or management discussion. It is a regulatory filing related to securities registration and employee stock plans. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for filings that do not fit other specific categories and includes SEC registration statements like Form S-8.
2001-07-16 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.